Latest News and Press Releases

Ardena’s Oss facility secures GMP approval for nanomedicine manufacturing, enhancing capabilities in innovative drug development.

New York, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Nanotechnology Market is projected to grow from USD 5.3 billion in 2024 to USD 74.9 billion by 2033, with a CAGR of 34.3%. ...

Pune, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The SNS Insider report indicates that, “Nanomedicine Market was valued at USD 223.6 billion in 2023 and is expected to reach USD 634.2 billion during the...

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...

ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...

New York, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight Nanomedicine is experiencing heightened demand,...

ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...

New York, United States , Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Global Nanomedicine Market Size is To Grow from USD 174.13 Billion in 2022 to USD 564.15 Billion by 2032, at a Compound Annual Growth...

Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, in a mouse model of multiple sclerosis  REDWOOD CITY, Calif.,...

Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global nanomedicine industry was valued at USD 198.9 Bn in 2020 and to reach USD 512.5 Bn by 2028 with a CAGR of 12.6% from...